DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
Smartwatches still can’t measure blood sugar on their own, but AI-powered CGMs are changing how glucose data is tracked and ...
Heald, a digital metabolic health platform, today announced that consumers who purchase a Dexcom Stelo or Abbott Lingo continuous glucose monitor (CGM) through Heald will now receive complimentary ...
The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
Diabetes technology news has been off to a fast start this year. Here are some highlights of MedTech Dive’s coverage from ...
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights: Revenue ...
Insulet has launched its Omnipod 5 Automated Insulin Delivery System and Omnipod Discover data management platform in Spain, expanding its European footprint ...
Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...
Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...
HawkEye 360, the global leader in signals intelligence data and analytics, today announced that the Space Rapid Capabilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results